
People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required. A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinical trial results show. Icodec now awaits approval by the U.S. Food and Drug… read on > read on >